首页> 美国卫生研究院文献>Antibodies >Antiphospholipid Antibodies: Their Origin and Development
【2h】

Antiphospholipid Antibodies: Their Origin and Development

机译:抗磷脂抗体:其起源和发展

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Antiphospholipid antibodies (aPL) are a hallmark of the antiphospholipid syndrome (APS), which is the most commonly acquired thrombophilia. To date there is consensus that aPL cause the clinical manifestations of this potentially devastating disorder. However, there is good evidence that not all aPL are pathogenic. For instance, aPL associated with syphilis show no association with the manifestations of APS. While there has been intensive research on the pathogenetic role of aPL, comparably little is known about the origin and development of aPL. This review will summarize the current knowledge and understanding of the origin and development of aPL derived from animal and human studies.
机译:抗磷脂抗体(aPL)是抗磷脂综合症(APS)的标志,它是最常见的血友病患者。迄今为止,已经达成共识,即aPL引起了这种潜在破坏性疾病的临床表现。但是,有充分的证据表明,并非所有的aPL都是致病的。例如,与梅毒相关的aPL与APS的表现没有关联。尽管已经对aPL的致病作用进行了深入研究,但相对而言,关于aPL的起源和发展所知甚少。这篇综述将总结从动物和人类研究中得出的关于aPL起源和发展的当前知识和理解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号